UnitedHealth Group (UNH)
(Delayed Data from NYSE)
$524.63 USD
+3.36 (0.64%)
Updated May 17, 2024 04:00 PM ET
After-Market: $524.00 -0.63 (-0.12%) 7:58 PM ET
3-Hold of 5 3
B Value A Growth F Momentum A VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$524.63 USD
+3.36 (0.64%)
Updated May 17, 2024 04:00 PM ET
After-Market: $524.00 -0.63 (-0.12%) 7:58 PM ET
3-Hold of 5 3
B Value A Growth F Momentum A VGM
Zacks News
UnitedHealth Group, Inc. is the largest health care services company in the world, serving over 50 million individuals in the United States as of 2019 and over 5 million internationally. The company provides a wide range of health care products and services, such as health maintenance organizations (HMOs), point of service plans (POS), preferred provider organizations (PPOs), and managed fee-for-service programs. UnitedHealth has the largest and most diverse membership base within the managed-care organization market, which gives it significant competitive advantages. It also has built its prescription drug business through OptumRx division, with the acquisition of Catamaran in 2015.
UnitedHealth Group (UNH) Stock Slides as Market Rises: Facts to Know Before You Trade
by Zacks Equity Research
In the latest trading session, UnitedHealth Group (UNH) closed at $526.55, marking a -0.86% move from the previous day.
UnitedHealth Group's (UNH) Arm Launches OptumRx Weight Engage
by Zacks Equity Research
UnitedHealth Group (UNH) enhances Optum Rx's offerings with the launch of the Weight Engage program.
5 Stocks Powering Dow ETF's 3-Month Outperformance
by Sweta Killa
The Dow Jones has been outperforming over the past three months, rising 5.8% compared with a 3.9% increase for the S&P 500.
Strength Seen in Cigna (CI): Can Its 16.7% Jump Turn into More Strength?
by Zacks Equity Research
Cigna (CI) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.
UnitedHealth Group (UNH) Stock Slides as Market Rises: Facts to Know Before You Trade
by Zacks Equity Research
In the most recent trading session, UnitedHealth Group (UNH) closed at $543.68, indicating a -1.11% shift from the previous trading day.
UnitedHealth (UNH) Unit Awarded a Medicaid Contract by AHCCCS
by Zacks Equity Research
UnitedHealth Group's (UNH) unit has been picked up by AHCCCS to serve members of the ALTCS EPD program, which will serve as a means to further expand the health insurer's statewide footprint.
Beat the Market the Zacks Way: Shopify, Lululemon, Telos in Focus
by Abhinab Dasgupta
Our time-tested methodologies were at work to help investors navigate the market well last week. Here are some of our key performance data from the past three months.
Should You Invest in the Fidelity MSCI Health Care Index ETF (FHLC)?
by Zacks Equity Research
Sector ETF report for FHLC
UnitedHealth Group (UNH) is a Top-Ranked Growth Stock: Should You Buy?
by Zacks Equity Research
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
UnitedHealth Group Incorporated (UNH) Is a Trending Stock: Facts to Know Before Betting on It
by Zacks Equity Research
Zacks.com users have recently been watching UnitedHealth (UNH) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
Why You Should Retain UnitedHealth Group (UNH) Stock Now
by Zacks Equity Research
Growing membership, expanding government business, strategic acquisitions, improving operating margin and solid growth outlook poise UnitedHealth Group (UNH) well for growth.
UnitedHealth Group (UNH) Ascends While Market Falls: Some Facts to Note
by Zacks Equity Research
In the latest trading session, UnitedHealth Group (UNH) closed at $548.28, marking a +0.2% move from the previous day.
Big Day on the Dow, +520 Points; ULTA Beats & Raises
by Mark Vickery
The Dow cleaned up this session: +520 points, +1.47%, led by Salesforce (CRM) coming off its impressive Q3 earnings report yesterday.
Analyzing Cigna & Humana Merger Talks: Opportunities & Obstacles
by Kaibalya Pravo Dey
The Cigna-Humana merger will provide the combined body with increased negotiation power with healthcare providers, pharmaceutical companies and other stakeholders.
UnitedHealth (UNH) Unveils its Latest Outlook: Key Takeaways
by Zacks Equity Research
UnitedHealth (UNH) expects the top line to be within the range of $400-$403 billion in 2024.
Should You Invest in the iShares U.S. Healthcare Providers ETF (IHF)?
by Zacks Equity Research
Sector ETF report for IHF
UnitedHealth Group (UNH) Suffers a Larger Drop Than the General Market: Key Insights
by Zacks Equity Research
In the latest trading session, UnitedHealth Group (UNH) closed at $543.59, marking a -0.64% move from the previous day.
Why UnitedHealth Group (UNH) is a Top Value Stock for the Long-Term
by Zacks Equity Research
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Investors Heavily Search UnitedHealth Group Incorporated (UNH): Here is What You Need to Know
by Zacks Equity Research
Zacks.com users have recently been watching UnitedHealth (UNH) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
Beat the Market Like Zacks: UnitedHealth, Casey's, Cencora in Focus
by Abhinab Dasgupta
Our time-tested methodologies were at work to help investors navigate the market well last week. Here are some of our key performance data from the past three months.
Centene (CNC) Up 8% Since Last Earnings Report: Can It Continue?
by Zacks Equity Research
Centene (CNC) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Why UnitedHealth Group (UNH) is a Top Momentum Stock for the Long-Term
by Zacks Equity Research
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Should You Invest in the Health Care Select Sector SPDR ETF (XLV)?
by Zacks Equity Research
Sector ETF report for XLV
Zacks Industry Outlook Highlights UnitedHealth, The Cigna, Humana, Centene and Molina Healthcare
by Zacks Equity Research
UnitedHealth, The Cigna, Humana, Centene and Molina Healthcare are part of the Zacks Industry Outlook article.
Should SPDR Dow Jones Industrial Average ETF (DIA) Be on Your Investing Radar?
by Zacks Equity Research
Style Box ETF report for DIA